Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to strengthen the long-term safety oversight of the Essure device following discontinuation of its U.S. sales
The FDA provides update on Essure postmarket review study as company prepares to halt sales of the device on December 31.
